egtazic acid has been researched along with African Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capoulade, C; Carlier, K; Coulaud, D; Lécluse, Y; Mangeney, M; Mishal, Z; Pritchard, LL; Taga, S; Tétaud, C; Tursz, T; Wiels, J | 1 |
| Ledbetter, JA; Press, OW; Shan, D | 1 |
| Akedo, H; Hara, T; Kojima, A; Matsumoto, M; Okada, M; Seya, T | 1 |
3 other study(ies) available for egtazic acid and African Lymphoma
| Article | Year |
|---|---|
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells.
Topics: Apoptosis; Burkitt Lymphoma; Calcium; Calcium Channels; Ceramides; Chelating Agents; Colforsin; Cyclic AMP; Egtazic Acid; Humans; Ion Transport; Ionophores; Signal Transduction; Trihexosylceramides; Tumor Cells, Cultured | 1997 |
Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antigens, CD20; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Calcium; Cell Cycle; Cell Division; Chelating Agents; Cross-Linking Reagents; Egtazic Acid; Goats; Humans; Mice; Receptors, Fc; Tumor Cells, Cultured | 1998 |
Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Topics: Antigens, CD; B-Lymphocytes; Burkitt Lymphoma; CD55 Antigens; CD59 Antigens; Cell Separation; Complement C3; Complement Pathway, Alternative; Egtazic Acid; Humans; Membrane Cofactor Protein; Membrane Glycoproteins; Receptors, Complement 3d; Tumor Cells, Cultured | 1992 |